Aortic valve sclerosis as a marker of active atherosclerosis

Current Cardiology Reports

Volumn 4, Issue 2, 2002, Pages 111-117

  Branch, Kelley R ^a   O'Brien, Kevin D ^a   Otto, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE; AORTA VALVE STENOSIS; ARTERIOSCLEROSIS; CALCINOSIS; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR; SCLEROSIS;

AORTIC VALVE; AORTIC VALVE STENOSIS; ARTERIOSCLEROSIS; CALCINOSIS; HUMANS; RISK FACTORS; SCLEROSIS;

EID: 0036514235     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-002-0022-8     Document Type: Article

References (39)

1. Lindroos M, Kupari M, Valvanne J, et al.: Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1993, 15:865-870.
2. Otto CM, Kuusisto J, Reichenbach DD, et al.: Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994, 90:844-853.
3. Stewart BF, Siscovick D, Lind BK, et al.: Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997, 29:630-634.
4. Mohler ER, Sheridan MJ, Nichols R, et al.: Development and progression of aortic valve stenosis: atherosclerosis risk factors -a causal relationship? A clinical morphologic study. Clin Cardiol 1991, 14:995-999.
5. Otto CM, Lind BK, Kitzman DW, et al.: Association of aortic valve sclerosis with cardiovascular mortality in the elderly. New Engl J Med 1999, 341:142-147.
6. Clark RE, Finke EH: Scanning and light microscopy of human aortic leaflets in stressed and relaxed states. J Thoracic Cardiovasc Surg 1974, 67:792-804.
7. Sahasakul Y, Edwards WD, Naessens JM, et al.: Age-related changes in aortic and mitral valve thickness: implications for two-dimensional echocardiography based on an autopsy study of 200 normal hearts. Am J Cardiol 1988, 62:424-430.
8. O'Brien KD, Reichenbach DD, Marcovina SM, et al.: Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996, 16:523-532.
9. Olsson M, Thyberg J, Nilsson J: Presence of oxidized low density lipoprotein in nonrheumatic stenotic rheumatic valves. Arterioscler Throm Vasc Biol 1999, 19:1218-1222.
10. Cushing SD, Berliner JA, Valente AJ, et al.: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci 1990, 87:5134-5138.
11. Olsson M, Rosenqvist M, Nilsson J: Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol 1994, 24:1664-1671.
12. Olsson M, Dalsgaard CJ, Haegerstrand A, et al.: Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994, 23:1162-1170.
13. Mohler ER 3rd, Chawla MK, Chang AW, et al.: Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999, 8:254-260.
14. O'Brien KD, Kuusisto J, Reichenbach DD, et al.: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995, 92:2163-2168.
15. Speer MY, McKee M, Liaw L, et al.: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor in vivo [abstract]. Presented at American Heart Association Scientific Sessions, Anaheim, CA; November 2001.
16. Sauren AAH, Juijpers W, Van Steenhoven AA, Veldpaus FE: Aortic valve histology and its relation with mechanics: preliminary report. J Biomech 1980, 13:97-104.
17. Thubrikar MJ, Aouad J, Nolan SP: Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol 1986, 58:304-308.
18. Mohler ER 3rd, Gannon F, Reynolds C, et al.: Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
19. Ross R: Atherosclerosis: an inflammatory disease. New Engl J Med 1999, 340:115-126.
20. Simionescu N, Vasile E, Lupu F, et al.: Prelesional events in atherogenesis: accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol 1986, 123:109-125.
21. Edep ME, Shirani J, Wolf P, Brown DL: Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000, 9:281-286.
22. Roberts WC: The senile cardiac calcification syndrome. Am J Cardiol 1986, 58:572-574.
23. Hoagland PM, Cook EF, Flatley M, et al.: Case-control analysis of risk factors for presence of aortic stenosis in adults age 50 years or older. Am J Cardiol 1985, 55:744-747.
24. Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987, 59:998-999.
25. Gotoh T, Kuroda T, Yamasawa M, et al.: Correlation between lipoprotein (a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995, 76:928-932.
26. Mohler ER 3rd, Sheridan MJ, Nichols R, et al.: Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study. Clin Cardiol 1991:14:995-999.
27. Nassimiha D, Aronow WS, Ahn C, Goldman ME: Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001, 87:1313-1314.
28. Palta S, Pai AM, Gill KS, Pai RG: New insights in to the progression of aortic stenosis. Implications for secondary progression. Circulation 2000, 101:2497-2502.
29. Boon A, Cheriex E, Lodder J, et al.: Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997, 78:472-474.
30. Fried LP, Borhani O, Enright P, et al.: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991, 1:263-276.
31. Exadactylos N, Sugrue DD, Oakley CM: Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br Heart J 1984, 51:121-124.
32. Vandenplas A, Willems JL, De Geest H: Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol 1988, 62:117-120.
33. Aronow WS, Ahn C, Shirani J, et al.: Comparison of frequency of new coronary events in older persons with mild, moderate, and severe valvular aortic stenosis with those without aortic stenosis. Am J Cardiol 1998, 81:647-649.
34. Lindroos M, Kupari M, Heikkila J, Tilvis R: Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993, 21:1220-1225
35. Ortlepp JR, Hoffman R, Ohme F, et al.: The vitamin D receptor genotype predisposes the development of calcific aortic valve stenosis. Heart 2001, 85:635-638.
36. Shavelle DM, Takasu J, Budoff M, et al.: Association of HMG-CoA reductase inhibitor ("statin") use with decreased aortic valve calcium accumulation. Lancet 2002, in press.
37. Pohle K, Maffert R, Ropers D, et al.: Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001, 104:1927-1932.
38. Navaro GM, Tiong IY, Pearce GL, et al.: Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001, 104:2205-2209.
39. Aronow WS, Ahn C, Kronzon I, et al.: Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001, 88:693-694.